ArticleInternational journal of biological sciences2021

Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.

Haoran Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.